goglides.dev
ResearchFinanceTechCompaniesDiscussion
Search
Sign inJoin
goglidesgoglides.devSocial learning for Finance and Tech.
TermsPrivacyDisclaimerModerationAcceptable UseDMCAContact
Company / Finance

Zimmer Biomet Holdings, Inc.

ZBH · NYSE

ZBH has an annual revenue baseline of $8.2B, latest revenue marker of $2.1B Q1 2026, annual net income of $705.1M and cash of $424.2M. The thesis depends on revenue durability, margins, cash conversion and balance-sheet discipline.

FollowAdd to WatchlistAsk Question
NYSEZBHCoverage BootstrapZimmer Biomet Holdings, Inc.
OverviewFinancialsResearchTimelineCompareValuationScorecardDiscussion
Latest ReportMay 20, 2026Zimmer Biomet: medtech durability still has to prove procedure demand, margin quality and cash conversionView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->
Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.

Sign in to continue